Trade Pfizer ^PFE

Pfizer Inc. $PFE Shares Sold by Canal Insurance CO

Symbol: ZPFE Security name: Pfizer (PFE) BMO CDR (CAD Hedge

Should Pfizer's Oncology Win And Obesity Push Require Action From Pfizer (PFE) Investors?

Promising Pharmaceutical Stocks To Add to Your Watchlist - January 13th - Markets Daily

Amneal Pharmaceuticals Eyes 2026 Growth at JPMorgan, Crexont Sales Seen Doubling in 2025 - Daily Political

Tema Etfs LLC Purchases Shares of 93,166 Pfizer Inc. $PFE

Pfizer Inc. (NYSE:PFE) is favoured by institutional owners who hold 66% of the company

Bogart Wealth LLC Raises Holdings in Pfizer Inc. $PFE

Pfizer Inc. (NYSE:PFE) Given Consensus Rating of "Hold" by Analysts

TD Private Client Wealth LLC Has $5.95 Million Stock Position in Pfizer Inc. $PFE - Daily Political

ERN GENTURIS guideline on counselling on reproductive options for individuals with a cancer predisposition syndrome (including genturis)

Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

UBS Likes Pfizer's MTSR Obesity Deal but Stays Neutral on PFE

Pfizer Talking to Trump Administration About Priority Vouchers

Dividend Stocks To Add to Your Watchlist - January 12th - Markets Daily

Pfizer Inc. $PFE Shares Sold by Bay Colony Advisory Group Inc d b a Bay Colony Advisors

Pfizer announces results from Cohort 3 of BREAKWATER trial | Markets Insider

Cohort 3 analysis from the BREAKWATER study shows objective

Madrigal Pharmaceuticals (MDGL) Is Down 13.4% After Pfizer MASH Deal And Wolfe Downgrade - What's Changed

Moderately bullish activity in Pfizer with shares up 0.38% | Markets Insider

Big Pharma turf war erupts: Bayer sues vaccine makers over alleged stolen mRNA technology - NaturalNews.com

Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor

Assessing Adaptive Biotechnologies (ADPT) Valuation After New Pfizer Deals And Digital Biotechnologies Financing

New study links COVID vaccines to autoimmune, cardiovascular and neurological damage-calls for immediate halt to gene-based shots - NaturalNews.com

Park Avenue Securities LLC Raises Stake in Pfizer Inc. $PFE - Daily Political

Monsanto Sues COVID-19 Vaccine Manufacturers, Alleging Copyright Infringement | ZeroHedge

Merck Negotiates $32 Billion Acquisition of Revolution Medicines to Boost Cancer Drug Pipeline, ETPharma

How Pfizer's AI and Precision Oncology Deals At Pfizer (PFE) Have Changed Its Investment Story

Merck in Talks to Buy Biotech Revolution Medicines, FT Says (2)

Top Undervalued Stocks to Watch in 2026 - IG UK

Top Undervalued Stocks to Watch in 2026 | IG South Africa

Pfizer Turns To AI Where Drug Risk Is Highest

Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment

BioNTech (BNTX) Is Up 5.1% After 90%-Effective COVID Data Raises New Franchise Questions

Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach | Malay Mail

Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis

Bayer sues Covid-jab makers, alleging patent violation

KLP Kapitalforvaltning AS Grows Position in Pfizer Inc. $PFE

Top Pharmaceutical Stocks To Add to Your Watchlist - January 7th - Daily Political

Bayer's Monsanto Files Lawsuit Against Pfizer, BioNTech, and Moderna Over mRNA Patent Infringement, ETPharma

Big Pharma race to snap up biotech assets as $170 billion patent cliff looms

Securian Asset Management Inc. Decreases Stock Position in Pfizer Inc. $PFE - Daily Political

BioNTech (NasdaqGS:BNTX) Valuation Check After Positive COVID 19 Vaccine Efficacy Data

Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study

iShares Select Dividend Fund Has A Surprisingly High Yield For Retirees

Pfizer (NYSE:PFE) Stock Price Up 1.1% - Still a Buy? - Daily Political

Robeco Institutional Asset Management B.V. Has $290.44 Million Holdings in Pfizer Inc. $PFE - Markets Daily

Pfizer's 2026 Drug Price Reset Could Be A Game Changer For Pfizer (PFE)

Pfizer Inc. $PFE Position Cut by Commonwealth Equity Services LLC

Pfizer (PFE) Plans Price Increases on About 80 Medicines Despite Broader Pricing Deals

Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study

Assessing Pfizer (PFE) Valuation After Recent Share Price Weakness And Dividend Support

ADPT: MRD Platform And Pfizer Agreements Will Support Long-Term Cash Flow Upside

Daymark Wealth Partners LLC Sells 52,529 Shares of Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Allen Wealth Management LLC

D.A. Davidson & CO. Acquires 70,161 Shares of Pfizer Inc. $PFE - Daily Political

Assessing Pfizer (PFE) Valuation As Recent Trading Momentum Shows Signs Of Slowing

Capital Advisors Inc. OK Grows Stake in Pfizer Inc. $PFE

Verity & Verity LLC Has $32.72 Million Stock Holdings in Pfizer Inc. $PFE - Markets Daily

Pfizer Inc. $PFE Shares Sold by Financiere des Professionnels Fonds d investissement inc. - Markets Daily

Pharmaceutical Stocks To Keep An Eye On - January 3rd - Stock Observer

Pfizer Inc. $PFE Shares Purchased by Verity & Verity LLC - Stock Observer

Financiere des Professionnels Fonds d investissement inc. Sells 22,061 Shares of Pfizer Inc. $PFE - Stock Observer

Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma

Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial

Moderately bullish activity in Pfizer with shares up 1.1% | Markets Insider

Dividend Stocks To Follow Now - January 2nd - Markets Daily

Pfizer (PFE) Navigates Patent Losses With Strategic Cost Controls, BMO Capital Reaffirms Outperform Rating

Cough syrup controversy: Segment sees a "cautious" shift by consumers and doctors, say industry -watchers

Tectonic Advisors LLC Buys 49,737 Shares of Pfizer Inc. $PFE - Stock Observer

Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump - Yahoo News Canada

Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer

Drug Prices Surge: 350 Medications Facing Increases Amid Trump Administration Pressure, ETPharma

Brokers Set Expectations for Pfizer's Q4 Earnings (NYSE:PFE)

Pfizer Inc. $PFE Shares Purchased by Ascent Group LLC

Promising Dividend Stocks Worth Watching - December 31st - Markets Daily

Despite Trump pressure, Big Pharma is raising hundreds of drug prices - Yahoo News Canada

Drugmakers hike US prices on 350 medicines despite pressure from Trump

Pfizer and GSK Lead 2026 U.S. Drug Price Hikes

Lupin's Bofanglutide: A Game-Changer in India's Weight-Loss and Diabetes Market, ETPharma

Pfizer (PFE) Braces for Bumpy Years as Growth Pushed Out to 2029

The Skin of Color Society (SOCS) Reports an Impactful Year of Progress, Expansion, and Innovation Toward Advancing Knowledge and Excellence in Patient Care

The past three years for Pfizer (NYSE:PFE) investors has not been profitable

Pfizer Inc. $PFE Shares Acquired by Fort Washington Investment Advisors Inc. OH

Mattson Financial Services LLC Has $665,000 Stock Position in Pfizer Inc. $PFE - Stock Observer

Option traders moderately bearish in Pfizer with shares down 0.14% | Markets Insider

Live Oak Private Wealth LLC Has $449,000 Stake in Pfizer Inc. $PFE

Ethic Inc. Lowers Holdings in Pfizer Inc. $PFE | MarketBeat

Live Oak Private Wealth LLC Reduces Stock Position in Pfizer Inc. $PFE - Daily Political

Top Pharmaceutical Stocks To Follow Now - December 28th - Stock Observer

Pfizer Inc. $PFE Shares Sold by Meyer Handelman Co.

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision

Stock price forecast: 4 S&P 500 Stocks for 2025

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Week ahead: Apple earnings land as Fed seen holding rates

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk